A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

This study examines the impact of an online decision tool for patients with early stage invasive breast cancer. The study is a randomized controlled trial (RCT) of 444 newly diagnosed patients, recruited from multiple surgical practices in two SEER catchment areas. Participants will be randomized to receive either a basic version of a decision tool (similar to existing website with breast cancer information) or an enhanced version (featuring a knowledge building component, a values clarification exercise, and a patient activation module). Our hypothesis is that patients who use the enhanced version of the tool will have greater knowledge of their test and treatment options, have a higher rate of high quality (i.e., informed, preference-concordant) decisions, and report more positive appraisal of the decision-making process.

Key facts

Study ID

NCT01840163

Run by

University of Michigan

People needed

537

Starts

2014-02-01

Expected to finish

2017-09-01

Last updated by the study team

2018-11-08

Who can join

Age: 21 and older, up to 84. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Stage 1-2 invasive breast cancer diagnosis,
• DCIS
• Ability to read English

You may not qualify if…

• Male

Where it is running

• University of Michigan Medical School — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.